Data / Form D filings / LTC BioSciences, Inc
LTC BioSciences, Inc: Form D filing
LTC BioSciences, Inc, a biotechnology company in Gainesville, FL, filed a Form D with the SEC in 2018. The latest, on September 14, 2018, reports an offering of $12 million with nothing sold yet.
Find out what LTC BioSciences, Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4160 NW 50TH DRIVE, SUITE 1360, Gainesville, FL, 32606
- Phone
- (352) 462-1600
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Florida
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1752210
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 14, 2018 | New notice | $12,000,000 | $0 | $12,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul Carney | Executive Officer | |
| Lynn Brewer | Executive Officer | |
| Caryn Colgan | Executive Officer |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
- RHEOS MEDICAL CORP. $387,773 · Oct 7, 2026
- DIGITAL ETHER COMPUTING, LLC $625,000 · Sep 23, 2026
- Jupiter Biomedical Research, Inc. $30,000 · Sep 21, 2026
- Kaida BioPharma Inc. $1.6 million · Sep 1, 2026
- StrataBio Inc. $25,000 · Aug 31, 2026
- LUREX BIO, INC $150,000 · Aug 31, 2026
- EXUMA Biotech Corp. $70 million · Aug 20, 2026
- CRESCEL LLC $1.1 million · Aug 19, 2026
- EnduraFAST Inc. $50,000 · Aug 17, 2026
Every Form D from the week of Sep 10, 2018 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what LTC BioSciences, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.